5 Key Takeaways
-
1
Personalized dry eye care begins by understanding patients’ symptoms, frustrations, and goals and correlating their experiences with clinical findings.
-
2
The SPEED survey and tests of tear osmolarity, MMP-9, tear volume, and tear breakup time can help characterize disease and guide treatment choices.
-
3
The author describes combining established therapies with newer options because dry eye is chronic and has no single curative therapy.
-
4
The therapies discussed include supplements, perfluorohexyloctane, acoltremon, canalicular gel, thermal gland expression, and intense pulsed light.
-
5
The author uses perfluorohexyloctane for evaporative dry eye or MGD, acoltremon for aqueous deficiency, and canalicular gel alone or with topical medications.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.